Abstract pharmaceutical regulatory pathway with a capsule and digital dossier

UAE market entry & lifecycle support

Enter the UAE.Stay compliant. Grow with confidence.

ViaFarma helps international manufacturers enter the UAE and supports established healthcare companies with regulatory affairs, product registration, market access and lifecycle compliance.

Regulatory clarity Regional insight Commercial thinking
FROM PRODUCTTO MARKET
Registration
Compliance
Coding & coverage
Launch readiness
Market access
Partner match

One connected path. Every critical step.

From first assessment to lifecycle compliance.

Market entryRegistration & complianceMarket accessLocal operations

Start from where you are

Two starting points. One connected UAE pathway.

Choose the route that reflects your current position. We then shape the scope around the product, evidence, ownership model and commercial objective.

For international companies

I want to enter the UAE market

For manufacturers, brand owners and healthcare innovators preparing a product or portfolio for the UAE.

  1. Assess
  2. Classify
  3. Prepare
  4. Register
  5. Launch
Explore the market-entry pathway
For UAE-based companies

I already operate in the UAE

For MAHs, distributors, medical warehouses and healthcare teams managing approved products, portfolios and market-access challenges.

  1. Maintain
  2. Resolve
  3. Optimize
  4. Expand
Explore ongoing UAE support

Not sure which pathway applies?Start with a regulatory and commercial readiness assessment before committing resources.

Discuss your product

Solutions by business objective

Specialist services connected around the outcome you need.

We do not start with a registration form. We start by understanding the product, its classification, evidence, ownership model and commercial objective.

Who we are

Local insight.
International standards.

Founded in Abu Dhabi in 2021, ViaFarma is a UAE-based pharmaceutical consultancy built for companies navigating complex, fast-moving healthcare markets.

Our multidisciplinary approach unites regulatory affairs, commercial strategy, medical communication and operational support—so your next step is always connected to the bigger goal.

View founder profile
Our vision

Empowering pharma growth through compliance, creativity and connection.

We help clients turn regulatory complexity into sustainable commercial progress.

Integrity

Honest, transparent and professional partnership.

Excellence

High standards from strategy through execution.

Innovation

Modern solutions shaped around market needs.

Accountability

Clear ownership, disciplined delivery and results.

Regional market navigation

One connected path across regulated markets.

From the UAE to Jordan and the wider GCC, we combine authority-level detail with practical commercial understanding.

01

Frame

Opportunity, product and route-to-market assessment.

02

Prepare

Dossier, artwork, evidence and submission readiness.

03

Navigate

Authority communication, follow-up and approval support.

04

Grow

Launch, market access, brand and lifecycle support.

Why ViaFarma

A regional ally, not just a service provider.

End-to-end ownership

One partner from registration and training to brand, sourcing and export support.

Deep regulatory context

Specialized knowledge of pharmaceutical, nutraceutical and medical device pathways.

Commercially grounded

Advice shaped by feasibility, cost, timing and real market opportunity.

Strategic partner matching

A structured route from product opportunity to the right market partner.

Introductions are based on product fit, regulatory readiness and the strategic plan—not on a generic contact list.

01

Assess

Review the product, evidence, ownership model and commercial objective.

02

Plan

Define the regulatory route, target market and realistic partner profile.

03

Match

Identify and shortlist suitable distributors, agents or commercial partners.

04

Connect

Make the introduction and support the next regulatory and commercial steps.

Selected problem-solving experience

Clear thinking when regulatory and commercial paths become difficult.

These anonymized examples are drawn from professional regulatory and market-access experience. Client and product identities remain confidential.

eCTD dossier recovery

Turning four submissions from technical issues to VALID

Challenge

Four UAE eCTD dossiers required structural, content and validation corrections before they could progress.

Approach

The dossier structures and findings were reviewed, corrections were coordinated and the final sequences were verified.

Outcome

All four submissions were confirmed VALID and ready to proceed for authority review.

Regulatory classification

Clarifying the route to unlock a DOH application

Challenge

A healthcare product was stalled because it was unclear whether additional federal registration was required first.

Approach

The intended use, category and supporting product information were assessed against the applicable pathway.

Outcome

The clarification enabled the project to move forward to the appropriate DOH application stage.

Commercial feasibility

A go/no-go review that prevented an unviable launch

Challenge

A product opportunity faced strong competition, limited insurance coverage and realistic demand below the required commitment.

Approach

Classification, access conditions, competition, demand and commercial assumptions were reassessed together.

Outcome

A clear no-go recommendation avoided unnecessary registration, listing and launch investment.

Insights

Practical guidance for moving through the UAE healthcare market.

View all articles
Pharmaceutical Registration

Five common mistakes in UAE product registration

How pathway, documentation, local partners and post-approval planning affect a successful launch.

Read article
Medical Devices

UAE medical device registration in 2026

What manufacturers should prepare for EDE classification, representation, submission and lifecycle compliance.

Read article
Market Access

Abu Dhabi HTA: demonstrating value beyond approval

Why clinical, economic and budget-impact evidence increasingly matters for reimbursement decisions.

Read article

Clear answers

Frequently asked questions about ViaFarma.

Direct information to help companies identify the right pathway and next step.

What pharmaceutical consulting services does ViaFarma provide?

ViaFarma supports regulatory strategy, product registration, eCTD and technical files, pharmacovigilance, medical content, training, market access, insurance problem solving, product representation and strategic partner matching.

Which markets and authorities does ViaFarma work with?

ViaFarma is based in Abu Dhabi and supports projects across the UAE, GCC and Jordan, including pathways involving EDE, MOHAP, MOIAT, Dubai Municipality, DOH, DHA and JFDA.

Can ViaFarma help with DOH and DHA coding or insurance coverage barriers?

Yes. ViaFarma helps assess coding requirements, coordinate with relevant stakeholders and solve practical coverage, claims and market-access barriers in Abu Dhabi, Dubai and other emirates.

Can ViaFarma connect a product owner with a UAE distributor or commercial partner?

Yes. ViaFarma first reviews the product, evidence, market opportunity and strategic plan, then identifies and facilitates discussions with a suitable distributor, agent or commercial partner.

How can a company start working with ViaFarma?

Book a free 15-minute consultation or contact the team by email or WhatsApp. ViaFarma will clarify the immediate need, required information and practical next step.

Start a conversation

What is your next pharma milestone?

Tell us where you need clarity. We will help define the practical path forward.